Exec-Edge

Contributing Author

Recent Articles by Exec-Edge

Jul-13	The New Cyber Front Line: Pax8 Corporate VP Oguo Atuanya, CrowdStrike VP Daniel Danielli, Live from Pax8 Beyond 2026 CRWD Exec Edge
Jul-08	Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM GCTK GCTK +6.12% Exec Edge
Jul-06	The Cancer Therapy Strategy VERAXA Is Betting the Company On VRXA +7.35% VRXA +38.36% Exec Edge
Jul-02	CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty Oncology CDNA Exec Edge
Jul-02	VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone VRXA +18.26% VRXA +7.35% Exec Edge
Jun-30	Tackling the AI Security Crisis: Pax8's Rob Belgrave and SentinelOne's Steve Stone, Live from Pax8 Beyond 2026 S Exec Edge